Systematic review shows PCOS in obese women links to high MASLD and 2–4 fold increased cardiovascular and diabetes risks.

This systematic review examined the systemic health consequences of polycystic ovary syndrome (PCOS) in women, specifically highlighting a subset with obesity. The study mapped the 'extra-ovarian reach' of the condition, focusing on metabolic dysfunction-associated steatotic liver disease (MASLD), cardiovascular disease, and type 2 diabetes. The review characterizes these associations as a 'vicious cycle' and a 'shared metabolic soil' rather than establishing explicit causality for every link.

The data reveals that PCOS prevalence reaches 28.3% among women with obesity. Furthermore, MASLD prevalence is found to be 51.61% in obese patients who also have PCOS. The review reports a 2–4 fold increase in risk for both cardiovascular disease and type 2 diabetes within this population. These findings underscore the significant metabolic burden associated with the condition in the context of obesity.

Safety and tolerability data were not reported in the input. The review notes that fragmented care is insufficient for managing these complex, interconnected conditions. The authors argue that the systemic nature of PCOS demands a paradigm shift toward integrated, multidisciplinary management to effectively address the 'systemic damage' described. Specific certainty levels, such as GRADE, were not reported in the source text.

Key limitations include the lack of specific certainty metrics and the observational nature of the associations described. The text uses strong assertions like 'skyrockets' and 'far more than,' yet does not explicitly state causality for all associations. Clinicians should interpret these findings as evidence of strong correlation and shared pathophysiology rather than proven direct causation for every outcome.